Income investors chasing yield often overlook the quieter compounders: companies that have raised dividends for a quarter century or longer through recessions, pandemics, and rate cycles. That is the essence of the Dividend Aristocrats. For August, five names stand out as reliable payers with the balance-sheet muscle to keep the checks growing for decades.
Here is the setup. Each pick below has a verified multi-decade dividend growth streak, a defensible bull case backed by the latest earnings, and one caveat worth watching. These are research candidates for a lifelong-income sleeve, not short-term trades.
Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) just extended one of the most impressive streaks in corporate America. The board approved a 3.1% dividend increase to $1.34 per share quarterly, marking 64 consecutive years of dividend growth. Shares recently traded at $260.35, up 27.2% year to date, with the next $1.34 payment scheduled for September 8, 2026.
The bull case runs through oncology. Q1 2026 revenue hit $24.06 billion, up 9.9% year over year, with DARZALEX at $3.96 billion and CARVYKTI up 62.1% to $597 million. Management raised FY2026 guidance to adjusted EPS of $11.45 to $11.65. With a beta of 0.231 and a forward P/E near 22, JNJ delivers defensive characteristics at a reasonable multiple.
Risk: STELARA biosimilar erosion of 59.7% and $330 million in Q1 litigation charges plus Orthopaedics separation execution risk could weigh on near-term results.
Procter & Gamble (PG)
Procter & Gamble (NYSE:PG) has the longest streak of the group. Fiscal 2026 marked the 70th consecutive year of dividend increases and 136th consecutive year of dividend payments. The current quarterly payout of $1.0885 per share hits accounts on August 17, 2026. Shares recently traded at $144.55.
The bull case is cash return. Management plans approximately $10 billion in dividends and $5 billion in share repurchases in FY2027, with core EPS guidance of $6.89 to $7.11. Q4 FY2026 core EPS of $1.43 beat estimates, and the AI base case points to $161.46 with 11.7% upside.
Risk: A ~$1 billion after-tax commodity, energy, and transportation headwind in FY2027 with only 1% to 3% organic sales growth guided leaves little margin for execution slips.
McDonald’s (MCD)
McDonald’s (NYSE:MCD) is arguably the most contrarian pick here. Shares are down 9.63% year to date to $272.83, creating an entry point that has not existed in over a year. The quarterly dividend of $1.86 per share, up from $1.77 in 2025, pays on September 16, 2026.
The bull case is scale and loyalty. MCD’s loyalty program has ~220 million 90-day active users driving $40 billion in TTM systemwide sales, and management is targeting 50,000 global units by 2028. Operating margin sits at 46.1% with a 31.9% net margin. The AI model sees 16.01% upside to a $316.50 base case, closely matching the $316.06 analyst target.
Risk: Negative U.S. guest counts, negative China and France comps, and SG&A up 17% reflect real budget-consumer pressure that could persist into 2027.
Coca-Cola (KO)
Coca-Cola (NYSE:KO) is having a standout 2026, up 27.15% year to date to $87.71. The $0.53 quarterly payout lands October 1, 2026, and the dividend has climbed each year from $0.46 in 2023.
The bull case is momentum. Q2 2026 revenue of $13.38 billion beat estimates, with global unit case volume up 5% and Coca-Cola Zero Sugar up 16%. Management raised FY2026 guidance to 9% to 10% comparable EPS growth and $12.4 billion in free cash flow. CEO Henrique Braun said, "We delivered another strong quarter by staying close to the changing needs of our consumers and customers." The FIFA World Cup 2026 marketing catalyst is an under-appreciated tailwind.
Risk: Ongoing IRS tax litigation, Asia Pacific price/mix down 9%, and Q4 having six fewer selling days versus Q4 2025 could clip near-term optics.
Automatic Data Processing (ADP)
Automatic Data Processing (NASDAQ:ADP) rounds out the list. The payroll processor recently traded at $272.96, and the current $1.70 quarterly dividend pays on October 1, 2026. That is a notable jump from $1.54 in early 2025.
The bull case is compounding. Q4 FY2026 revenue rose 6.8% to $5.47 billion, and management guided FY2027 to revenue growth of 5% to 6% and adjusted diluted EPS growth of 9% to 11%. Client float income surged 15% to $355.4 million on a $41.0 billion average balance. CEO Maria Black noted, "AI is reshaping how work gets done… we’ve never been better positioned to deliver for our clients."
Risk: US pays per control growth slowing to 0% to 1% and AI disruption fears for the HCM industry are the primary overhangs.
The Bottom Line
Each of these five names has cleared the 25-year Aristocrat bar many times over, and each is generating enough free cash flow to keep raising payouts through the next cycle. The mix here spans healthcare, staples, restaurants, beverages, and payroll technology, which gives an income portfolio real diversification without sacrificing the multi-decade growth track record income investors depend on.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks